Virpax Pharmaceuticals(VRPX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 "We recently reported results for a Probudur™ Maximum Tolerated Dose Study, as we continue to make steady progress in anticipation of filing our IND. The results of this study, as expected, confirmed our belief that a single injection of Probudur was well- tolerated. Our studies to date continue to reaffirm our belief that Probudur's proprietary formulation has the potential to provide both immediate relief as well as sustained relief at the wound site, avoiding the need for additional free bup ...